The signs of a dangerous blood clot can vary depending on its location. Some people may also not experience any symptoms.

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.

Cardiologists reveal the unexpected symptoms of clogged arteries and underlying heart disease that you should know about.

In current European and American revascularization guidelines, RA grafts are now strongly endorsed as the second conduit for ...

Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...

More than 60 million American women have heart disease. "The statistics haven't improved enough," a women's heart doctor told ...

A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Abbott received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system.